Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02631460
What this trial is testing

S1 vs.Pemetrexed Plus Carboplatin in Patients With EGFR Wild Type Stage IIIB or IV Nonsquamous NSCLC

Who this might be right for
NSCLC
Sun Yat-sen University 470
Very early researchWithdrawnNCT04186988
What this trial is testing

[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT00029003
What this trial is testing

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Bronchoalveolar Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT00096486
What this trial is testing

Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 74
Testing effectiveness (Phase 2)Study completedNCT00006017
What this trial is testing

Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 42
Large-scale testing (Phase 3)UnknownNCT00519805
What this trial is testing

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

Who this might be right for
Lung CancerThromboembolism
Velindre NHS Trust 2,200
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Large-scale testing (Phase 3)Study completedNCT04475939
What this trial is testing

Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 666
Early research (Phase 1)Ended earlyNCT01714037
What this trial is testing

A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC]

Who this might be right for
Non-small Cell Lung Cancer
Debiopharm International SA 82
Large-scale testing (Phase 3)Study completedNCT03663205
What this trial is testing

A Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BeiGene 334
Early research (Phase 1)Study completedNCT00072072
What this trial is testing

Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT00900172
What this trial is testing

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 180
Testing effectiveness (Phase 2)Study completedNCT00816868
What this trial is testing

A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 62
Testing effectiveness (Phase 2)UnknownNCT00075517
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Large-scale testing (Phase 3)Study completedNCT01000025
What this trial is testing

PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 720
Not applicableStudy completedNCT00897533
What this trial is testing

Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 137
Testing effectiveness (Phase 2)UnknownNCT00006215
What this trial is testing

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Amgen
Not applicableWithdrawnNCT02106559
What this trial is testing

Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy

Who this might be right for
Stage III Malignant MesotheliomaStage IIIB Non-small Cell Lung CancerStage IV Malignant Mesothelioma+1 more
Ohio State University Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT01302808
What this trial is testing

Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
University of Texas Southwestern Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT00651508
What this trial is testing

Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 1
Next Page